Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. UNITEDHEALTHCARE SERVICES, INC.
Case Number:
2:16-cv-04870
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Appellate Advocates
- Boies Schiller
- Criden & Love
- Kessler Topaz
- Kirkland & Ellis
- Spector Roseman
- Stevens & Lee
- Zelle LLP
Companies
Government Agencies
Sectors & Industries:
-
September 19, 2018
UnitedHealthcare Can't Take Back Cephalon Antitrust Deal
A Pennsylvania federal judge has found that UnitedHealthcare Services Inc. is bound by a $125 million antitrust settlement its outside counsel reached with Cephalon Inc., as the insurer had given every indication that its lawyers were in the clear to sign on its behalf and in-house counsel actively chose not to read or challenge the final agreement.
-
April 20, 2018
Cephalon's $125M Antitrust Deal Is Valid, Atty Power Unknown
A contract outlining terms of Cephalon Inc.'s $125 million settlement, which resolved allegations it paid competitors to delay generic versions of its Provigil drug, is binding and enforceable, a Pennsylvania federal judge said Friday, but left undetermined if an insurer-claimant's attorneys were authorized to approve the deal.